Are you aware of the 5 OECD principles, which validate (Q)SAR models for their use in regulatory assessment of chemical safety? The …
“Upon becoming a member of Lhasa Limited, a world of opportunity opened up, both for the acquisition of new tools and for …
“As Adverse Outcome Pathways (AOPs) move from being an interesting scientific concept, to a useful practical application tool, this is an exciting …
Hello, my name is Daragh Connolly, I am one of the several Team Leaders in the Software Delivery function at Lhasa Limited. …
It is common knowledge to those submitting drug substances for regulatory assessment, that an in silico assessment of mutagenic potential may be …
“Our technology is designed by scientists, for scientists, in collaboration with industry stakeholders and regulators” At Lhasa Limited we often talk about …